2022 CCDS Symposium Call for Abstracts

The 2022 CCDS Symposium will be held in person in Park City, Utah from June 26th-27th. This conference is intended for members of the scientific and medical community, as well as the Cerebral Creatine Deficiency Syndromes (CCDS) patient and family community. 

Abstracts are now being solicited for presentations at the 2022 CCDS Symposium. If your submission is accepted, you will be allocated a speaking slot to deliver your presentation.  Please review the guidelines carefully in order to prepare your presentation successfully. 

Deadline for Submission: The deadline for submission of abstracts is April 30, 2022. A final schedule will be made available by May 15, 2022. 

Format for Presentation: All presentations will include a “live” component. Presenters, at their designated presentation time, will have the option to:

  • Present live from the podium on-site;
  • Present live, via our virtual platform*;
  • Virtual only: Pre-record the presentation and after it is displayed, be available to answer questions “live.”*

*We strongly encourage presenters to attend our event in person.

Please complete the following conference speaker abstract form with the required information. We thank you for your participation and research efforts.

2022 CCDS Symposium Abstract Submission Form

Please check the condition(s) your talk is relevant for. Even though talks will generally be focused on one or two conditions, we encourage speakers to consider and summarize at the end of the talk how the lessons learned in one condition apply to the other creatine deficiencies. This approach ensures our community stays strong and research progresses for all three creatine deficiencies.(Required)
Max. file size: 64 MB.

Consent

Please let us know if you consent to having your talk posted online and any additional feedback.
Symposium sessions will be recorded and posted online in ACD channels after the symposium. Do you consent to the online posting of your talk? (A digital document for consent will follow by email):(Required)